Drug profile

The FDA adverse-event record for Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31

196 FDA reports name Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31, a high-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#538 of 2,679
by report volume (all drugs)
196
adverse-event reports
10.2%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 ranks #538 of 2679 by total reports (196) and #538 of 1130 by death-coded share (10.2%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#538
This drug, reports of 2679
#538
This drug, death share of 1130

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 has 196 reports now versus 196 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 changes

Signature read: 196 reports place Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 in the upper third of FDA AER volume (#538 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
196
Total Reports
20
Deaths Reported
10.2%
Death-coded share of reports

Active Ingredients

Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 196

Most Affected Breeds

Retriever - Labrador 25
Shih Tzu 12
Terrier - Bull - American Pit 10
Terrier - Yorkshire 10
Retriever - Golden 9
Boxer (German Boxer) 8
Terrier - Jack Russell 7
Crossbred Canine/dog 6
Beagle 6
Chihuahua 6

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 61
Vomiting 57
Anorexia 36
Anaphylactoid reaction 34
Other abnormal test result NOS 25
Facial swelling (see also 'Skin') 22
Diarrhoea 22
Urticaria 19
Emesis 15
Lameness 15
Injection site swelling 14
Fever 14

Outcome Breakdown

Ongoing
107 (54.6%)
Recovered/Normal
60 (30.6%)
Euthanized
13 (6.6%)
Outcome Unknown
9 (4.6%)
Died
7 (3.6%)

Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31: high report volume in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

High-volume nationwide drug peers

Two openFDA-derived peer sets for Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other drugs by FDA report count (196 here).

S-Adenosylmethionine + Silybin 196 Spironolactone 196 Feline Leukemia Vaccine 195 Tildipirosin 197

Similar death-coded share

Nearest other drugs by death-coded share (10.2% here), distinct from the volume row.

Chlorhexidine 10.2% Leptospira Canicola L-15 Strain C-51;Leptospira Grippotyphosa 1550 Lot 10005 Str 10.2% Pyrantel 10.2% Corona Vaccine 10.1%

What to do with this drug

  • Compare Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31's report volume and death-coded share against similar drugs nationwide. See similar drugs
  • Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
  • Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 (#538 of 2,679 by report volume); death-coded 10.2%. PlainBreed drug row · report volume stamp 196 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →